Current Treatments for Progressive Multiple Sclerosis: Disease-Modifying Therapies
Characteristics of the placebo cohorts at baseline in the seven SPMS phase III RCTs Baseline variable (reference) European-SPMS NA- SPMS SPECTRIMS IMPACT Nordic-SPMS MIMS ESIMS IFNB-1b sc [18] IFNB-1b sc…